BeStock  
Stocks › Biotechnology › BNTX

BioNTech BNTX

US equityMarket cap rank #505BiotechnologyInfectious Disease
$97.26 −$1.05 (-1.06%)
Market open · Oct 1, 1:10 pm ET · After hours $98.30 0.00%
Open$97.59
Prev close$98.30
Day range$97.13 – $99.41
Volume300.0K
Market cap$24.43B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts14
Average target$126.85+30.4% vs. price
  • Buy 79%
  • Hold 21%
Low $96.00Now $97.26Avg $126.85High $140.00

Recent rating changes

The last 20 actions on file set price targets from $105.00 to $140.00, averaging $125.75.

DateFirmRatingTarget
28 Sep 2026 Morgan Stanley BUY $115.00
24 Sep 2026 Wells Fargo BUY $140.00
23 Sep 2026 CCORF BUY $136.00
21 Sep 2026 Morgan Stanley BUY $115.00
16 Sep 2026 UBS BUY $135.00
15 Sep 2026 CCORF BUY $136.00
15 Sep 2026 Berenberg Bank BUY $140.00
15 Sep 2026 Jefferies BUY $138.00
14 Sep 2026 BofA Securities BUY $122.00
14 Sep 2026 Morgan Stanley BUY $115.00
14 Sep 2026 BMO Capital HOLD $105.00
14 Sep 2026 Goldman Sachs BUY $127.00
8 Sep 2026 Morgan Stanley BUY $115.00
8 Sep 2026 BMO Capital HOLD $105.00
4 Sep 2026 Goldman Sachs BUY $127.00
31 Aug 2026 CCORF BUY $136.00
31 Aug 2026 Morgan Stanley BUY $115.00
31 Aug 2026 Citi BUY $125.00
28 Aug 2026 BMO Capital BUY $128.00
26 Aug 2026 Deutsche Bank BUY $140.00

Discussion

No comments yet — be the first to weigh in on BNTX.

Leave a comment

Scroll to Top